Men's Health News

RSS

Vaccines and boosters remain strong against current SARS-CoV-2 variants

In a recent study published in the Lancet Microbe journal, Australian researchers studied whether in-vitro neutralization titers could predict vaccine protection from SARS-CoV-2 variants.

17 Nov 2021

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

A new study indicates that the Pfizer vaccine induces antibodies in the breast milk against SARS-CoV-2.

17 Nov 2021

Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose

A nationwide study from Sweden investigates the effectiveness of COVID-19 vaccination against the risk of symptomatic infection, hospitalization, and death up to 9 months post-vaccination. This study is published on the Preprints with The Lancet website while awaiting peer review.

17 Nov 2021

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

A new study published in the journal Diagnostics was based on the hypothesis that detecting urinary SARS-CoV-2 nucleic acid––which may result in renal and cardiovascular endothelial destruction to facilitate viral access to the kidney parenchyma—may be used as a specific biomarker to indicate the severity of COVID-19.

16 Nov 2021

What genes affect the COVID-19 gender imbalance?

Many studies have established that coronavirus disease 2019 (COVID-19) is more infective in men than women, and men are more at risk of severe disease. While some have suggested that behavioral differences could explain increased transmission to men, this does not explain the more morbid prognosis.

16 Nov 2021

COVID-19 fatality disparities among working class in California

A recent study evaluates whether there is any correlation between the victims of COVID-19 and their occupation.

15 Nov 2021

Can COVID-19 vaccination lead to neurological complications?

A new review article discusses the neurological side effects due to SARS-CoV-2 vaccination.

14 Nov 2021

Regular blood tests can identify prostate cancer patients who are resistant to treatment

Regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with docetaxel, according to research presented at the NCRI Festival.

11 Nov 2021

Study highlights the increase in PSA screening for prostate cancer following revisions to USPSTF guidelines

In a large study led by Yale Cancer Center, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions to the recommendation by the U.S. Preventative Services Task Force (USPSTF) on screening.

11 Nov 2021

Risk of severe COVID-19 is rare among fully vaccinated individuals in England

A team of UK-based scientists has recently estimated the prevalence of vaccine breakthrough infections and severe disease in a large number of individuals fully vaccinated against coronavirus disease 2019 (COVID-19) in England.

10 Nov 2021

The impact of interventions and contact patterns on SARS-CoV-2 transmission

A recent study investigates the impact of varying interventions, consequent contact patterns, and the transmissibility of SARS-CoV-2.

9 Nov 2021

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections

Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).

9 Nov 2021

Drinking alcohol and not exercising are modifiable risk factors for SARS-CoV-2

New research from the United Kingdom suggests several factors that increased the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection involved higher alcohol use, Asian/Asian British ethnicity, and obesity. In addition, moderate but not vigorous exercise of more than 10 hours a week was associated with lower susceptibility to infection.

8 Nov 2021

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.

7 Nov 2021

Study identifies RNA molecule that suppresses prostate tumors

Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While the drugs are effective for a time, most patients eventually develop resistance to these therapies.

6 Nov 2021

Study shows most young Australians are willing to be tested for COVID

A new study explores the success of testing efforts among children and adolescents in Australia.

4 Nov 2021

Clear communication needed with college students regarding COVID-19 vaccine procedures and cost

A new study explores the acceptability and usage of COVID-19 vaccines among the student community.

4 Nov 2021

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.

4 Nov 2021

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

The study, recently published in The Journal of the American Medical Association, deduced that previous SARS-CoV-2 infection is associated with a statistically significant reduced hazard of breakthrough infection among recipients of both the BNT162b2 (Pfizer-BioNTech) and the mRNA-1273 (Moderna) vaccines.

3 Nov 2021

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Researchers evaluate the safety and immunogenicity of an influenza vaccine and mRNA-based COVID-19 vaccine that were administered concomitantly.

3 Nov 2021

Men's Health News

Vaccines and boosters remain strong against current SARS-CoV-2 variants

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

What genes affect the COVID-19 gender imbalance?

COVID-19 fatality disparities among working class in California

Can COVID-19 vaccination lead to neurological complications?

Regular blood tests can identify prostate cancer patients who are resistant to treatment

Study highlights the increase in PSA screening for prostate cancer following revisions to USPSTF guidelines

Risk of severe COVID-19 is rare among fully vaccinated individuals in England

The impact of interventions and contact patterns on SARS-CoV-2 transmission

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections

Drinking alcohol and not exercising are modifiable risk factors for SARS-CoV-2

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

Study identifies RNA molecule that suppresses prostate tumors

Study shows most young Australians are willing to be tested for COVID

Clear communication needed with college students regarding COVID-19 vaccine procedures and cost

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News